Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Dabigatran etexilate (Primary) ; Aspirin
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms DEA-LAA
- 09 Oct 2018 Status changed from not yet recruiting to recruiting.
- 25 Jul 2018 Planned initiation date changed from 1 Jul 2018 to 1 Aug 2018.
- 04 Jun 2018 New trial record